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Protein quantification at proteome-wide scale is an important aim, enabling insights into fun-
damental cellular biology and serving to constrain experiments and theoretical models. While
proteome-wide quantification is not yet fully routine, many datasets approaching proteome-
wide coverage are becoming available through biophysical and MS techniques. Data of this
type can be accessed via a variety of sources, including publication supplements and online
data repositories. However, access to the data is still fragmentary, and comparisons across
experiments and organisms are not straightforward. Here, we describe recent updates to our
database resource “PaxDb” (Protein Abundances Across Organisms). PaxDb focuses on protein
abundance information at proteome-wide scope, irrespective of the underlying measurement
technique. Quantification data is reprocessed, unified, and quality-scored, and then integrated
to build a meta-resource. PaxDb also allows evolutionary comparisons through precomputed
gene orthology relations. Recently, we have expanded the scope of the database to include
cell-line samples, and more systematically scan the literature for suitable datasets. We report
that a significant fraction of published experiments cannot readily be accessed and/or parsed
for quantitative information, requiring additional steps and efforts. The current update brings
PaxDb to 414 datasets in 53 organisms, with (semi-) quantitative abundance information cov-
ering more than 300 000 proteins.
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1 Introduction
Data processing and data reuse in proteomics remain chal-
lenging, more so than in other fields such as transcriptomics
or genomics [1, 2]. On the one hand, this is due to the sheer
complexity of the proteome—where cellular proteins are ex-
pressed in a large diversity of isoforms and modifications,
over a huge dynamic range, and in a variety of cellular local-
izations and biochemical contexts [3, 4]. On the other hand,
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the technical and conceptual advances in proteomics cur-
rently happen so fast that it remains a challenge to unify and
critically appraise all of the data as it arrives [5–7]. Neverthe-
less, to achieve a deep quantitative coverage of the complete
proteome is an essential milestone in the characterization
of any model organism or tissue of interest, providing an
important baseline for subsequent studies.
A growing number of online resources are dedicated to
the processing and dissemination of proteomics data; they
are operating at various degrees of postprocessing and data
integration. Of these, the largest repositories of primary, raw
data are those that are organized in the ProteomeXchange
consortium [8]: PRIDE [9], PeptideAtlas [10], MassIVE [11],
and PASSEL [10]. Building on these raw data collections as
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well as on additional curation, submission, and/or reprocess-
ing, a number of additional resources exist. These typically
offer higher levels of integration and standardization, but are
sometimes alsomore specialized in terms of scope and cover-
age. They include GPMDB [12], MOPED [13], ProteomicsDB
[14], MaxQB [15], and Human Proteome Map [16]. In ad-
dition, other databases whose primary focus is perhaps not
exclusively on proteomics may also contain information on
protein abundances, notably UniProt [17] and NextProt [18].
Here, we describe the latest updates to (and recent changes
in) our protein abundance meta resource Protein Abun-
dances Across Organisms (“PaxDb”) ([19], see Fig. 1). Sim-
ilar to some of the above resources, PaxDb provides access
to quantitative proteomics information, but in addition it has
some unique priorities and features:
(a) Its primary focus is on consistency and comparability,
both between datasets as well as between organisms.
This is achieved by remapping all abundance informa-
tion onto the same reference space of protein sequences
and genome annotations, and by providing precomputed
orthology relationships that allow comparisons between
organisms, at the protein family level, across the entire
tree of life.
(b) PaxDb is “locus-centric”: information on alternative pro-
tein isoforms or PTMs is collapsed, down to the level of
the single, protein-coding gene locus. This is a conscious
decision, aiming to facilitate data interpretation and user
interaction, and it should be useful in all scenarios where
“proteoform” resolution [3] is not required.
(c) PaxDb introduces a unique quality estimate, which ap-
plies at the level of entire datasets, as opposed to indi-
vidual peptides or proteins. This metric aims to describe
how well the observed spread of abundance values in
a given dataset covers and delineates known functional
groupings of proteins (e.g. protein complexes). The met-
ric is called the “interaction consistency score” [19], and
allows comparisons between datasets irrespective of the
data source or measurement technique.
(d) When populating PaxDb, datasets are chosen and filtered
manually, so as to reflect largely unperturbed, “wild-type”
cells, tissues, and organisms.
(e) PaxDb is purely a meta-resource–it does not currently
accept user submissions. All its data are imported from
primary proteomics databases or from publication sup-
plements; the original search parameters, false discovery
rates, and other technical settings are left unchanged.
(f) For each organism or tissue that has already been
addressed by multiple available experiments/datasets,
PaxDb conducts a weighted averaging to produce an inte-
grated “best-estimate” dataset guided by the above quality
estimates [19].
(g) Lastly, PaxDb presents its information in an intuitive and
simple web interface, which is enriched with accessory
information regarding the annotation, structure, and in-
teraction partners of the various proteins.
2 Data updates
The update process of PaxDb is partly manual, partly auto-
matic, and it occurs on a time-scale of roughly once or twice
a year. The growth of datasets and the number of organisms
so far is tabulated in Fig. 2A. Care is taken not to exclude
nonstandard datasets such as those based on biophysical or
single-cell measurements; however, datasets are generally in-
cluded only if they represent a mostly unperturbed, “normal”
and physiological state of cells. Tissues and cell-lines are an-
notated with controlled vocabularies; in the case of tissues
we use the Uberon ontology [20], which natively allows cross-
species comparisons of homologous tissues/organs.
For the current update to version 4.0, we started with a
manual search for publications describing possible datasets
of interest. This included keyword searches and forward cita-
tion analysis of landmark papers, but we also systematically
scanned all publications in three pertinent journals (MCP, J
Prot Res, Proteomics), as well as all publication output of six
major labs operating in high-throughput proteomics. The ini-
tial results were filtered down to 37 candidate publications,
based on the following criteria: (i) studies should be pub-
lished after August 2012 and not yet be contained in PaxDb,
(ii) coverage should be at least 20% of the predicted proteome,
or at least 20 000 peptide-spectrum matches in case of MS
data, (iii) abundance values must cover at least three orders
of magnitude, (iv) there should be no biased subfractiona-
tion (e.g. restricted to organelles, compartments, or specific
modifications), (v) datasets must be parsable for absolute pro-
tein quantification data; this excludes purely relative quantifi-
cations, and (vi) datasets must address mainly unperturbed
samples in normal, physiological state; this excludesmutated,
stressed, or diseases samples.
The same set of criteria were then applied to filter recent
datasets stored in three large proteomics data repositories:
PRIDE [9], GPMDB [12], and PeptideAtlas [10]. In the case
of PRIDE, datasets were accessed via the PRIDE BioMart if
“complete” submissions were available, and via the pepXML
format in case of selected “partial” submissions. In the case
of GPMDB, a recent new feature of the website that al-
lows the aggregated access to peptide information for each
taxon/organism, was used. From PeptideAtlas, data were im-
ported via the so-called “builds.” GPMDB and PeptideAtlas
are convenient data sources, but since the peptides cannot
easily be traced back to the original experiments/publications,
these data collections have to be taken as they are. Thus they
may include some nonphysiological, subfractionated, or mu-
tated samples—although in the case of PeptideAtlas, builds
that hinted at this already in their annotation were blocked
entirely.
Our data import procedure encountered many proteomics
experiments multiple times (see Fig. 2B). Overall, redun-
dancy was avoided by importing a given experiment via the
most convenient access route (the two recent, large mapping
efforts of the human proteome, for example, were imported
via PRIDE).
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Figure 1. The PaxDb website. Screenshot of the entry page of the PaxDb website, at http://paxdb-org/. Model organisms can be browsed
via the navigable taxonomy to the left; proteins of interest are accessible directly as well, via a variety of identifiers and full-text searches
(input box at top of the page).
Finally, a new development with release 4.0 of PaxDb is
the inclusion of protein abundance information from cell-
line samples. Cell-lines are unique in that they cannot be
considered to be fully physiological and unperturbed, so their
inclusion inPaxDb is somewhat of an exception to our normal
import rules. However, cell-lines represent a significant frac-
tion of the available data and their proteome expression sta-
tus is of great interest for everyday lab work. Hence, datasets
for 35 different cell-lines (including human induced pluripo-
tent cells, as well as human and mouse embryonic stem
cells), were included in this update; their biological origin
is annotated using the “Cellosaurus” controlled vocabulary.
Figure 2. Data updates for version 4.0. (A) Growth of datasets and organisms covered by PaxDb. Note that PaxDb focuses mainly on
normal, unperturbed, physiological cells, and tissues—some prominent, published datasets are thus not included. (B) Sources for the new
data in PaxDB version 4.0 (i.e. not already contained in version 3.0; the counts in the Venn diagram represent “publications” as opposed to
“samples” or “replicates”). Only published data, according to the references stated at the respective sources, is included. Panel (B) focuses
on data availability—datasets found at multiple sources are imported only once, from the most convenient/applicable source.
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Cell-lines are available for browsing and searching, but typ-
ically are not selected to contribute to the “best-estimate”
integrated datasets in PaxDb.
3 Rescaling and quality scoring
As introduced and described previously [19], datasets in
PaxDb are rescaled to a common abundance metric (“parts
per million”), and also ranked via a universally applicable,
albeit somewhat indirect quality score. For the rescaling, the
datasets are first parsed or processed such that the data re-
flect proportional abundances of whole protein molecules
(i.e. proportionality to counts of complete, individual protein
molecules, not to molecular weights, protein volumes, or di-
gested peptides). In the case of spectral counting data, this
is done via an in-house pipeline that takes into account pro-
tein sizes and estimated relative detectabilities of peptides
[19, 21]. For other datasets, the procedures depend on the
type of data and the type of quantitative information that is
provided (datasets that cannot be converted to proportional
abundances of entire proteinmolecules are discarded). Then,
the proportional abundances are rescaled linearly to add up
to one million; this means the abundance of each protein of
interest is finally expressed in “parts per million,” relative to
all other proteins in a sample. While this metric cannot be
directly converted to “molecules per cell,” it has the advantage
of being comparable/meaningful across cells of different vol-
umes, or across tissues of different cellular and extracellular
compositions.
For the quality scoring, we identified a test that can be
applied to any organism and to any abundance dataset, al-
beit at the cost of providing an indirect quality estimate only
[19]. This test relies on the assumption that proteins which
are interacting physically in a protein complex, or function-
ally in a pathway or metabolic process, should have a ten-
dency to be expressed at similar abundance levels. This is
merely a tendency, of course, and numerous exceptions to
this assumption exist. However, globally, the abundance ra-
tios of functionally interacting proteins are clearly closer to
one than those of randomly chosen protein pairs [19], and
this signal can be used to provide a relative ranking between
datasets, given a constant and externally provided network
of functional links between proteins. To compute this score,
we first import protein–protein interaction information from
the STRING database [22], separately for each organism in
PaxDb. For a given protein abundance dataset, we then com-
pute the absolute log abundance ratios of all pairs of proteins
annotated to be functionally linked. The median of these ab-
solute log abundance ratios represents an indirect quality
metric: the closer it is to zero, the better (i.e. the more there
is consistency between abundance values and functional an-
notations such as protein complexes or pathways). We then
compute a background expectation for this metric, by per-
muting the abundance values in a given dataset randomly,
and recomputing the median log abundance ratios. The per-
mutation is repeated several times, yielding a distribution of
medians. The actually observedmedian is then expressed as a
Z-score distance to the random distribution ofmedians—this
distance is termed the “interaction consistency score.”
4 False discovery rates
Since PaxDb does not reprocess raw MS data, and since it
does not reexecute peptide-spectrum matching searches, the
search parameter settings and false discovery rates (FDR) of
the original submitters are always retained. However, there
is controversy as to what extent false discovery rates repre-
sent a problem, especially as they propagate through larger
integrated data collections [23]. To reestimate FDRs in an
independent way, Ezkurdia et al. proposed to focus on a
set of proteins that should not be expected to be observed
in the vast majority of human tissues, namely human ol-
factory receptors [23]. Because there are several hundred of
these receptors encoded in the human genome, they do rep-
resent a broad and universal test set of likely “false-positive”
protein identifications (except, of course, for samples origi-
nating in nasal tissues and perhaps some other, inherently
“leaky” tissues [24]). We have implemented this test on all hu-
man abundance datasets in PaxDb 4.0, and indeed observe
variable levels of inferred FDR across datasets (Supporting
Information Table 1). This led us to block a small number of
datasets from further inclusion in PaxDb, and the remainder
of the data usually exhibit estimated FDRs of 5% or better,
many even at 1% or better. Despite reasonably low FDRs
throughout, false discovery identifications generally remain
a pressing problem, since they will disproportionally affect
the abundance estimates of lowly expressed proteins.
5 Stoichiometries and abundances on the
tree of life
One of the unique features of PaxDb is its seamless com-
parability of data across organisms. This allows insights in
protein abundance evolution, such as abundance conserva-
tion in the eukaryotic core proteome [21,25,26], cost-diversity
tradeoffs during evolution [27], or the fate of paralogs during
evolutionary network rewiring [28]. Orthology relationships
in PaxDb are precomputed, through the eggNOGmechanism
[29], and can be browsed at various levels of phylogenetic
depth (e.g. “mammals,” “animals,” or “eukaryotes”). To il-
lustrate the usefulness of these comparisons, Fig. 3 shows
abundance comparisons at various levels of organismal re-
latedness. At one end of the spectrum, closely related or-
ganisms such as mouse and human show a relatively high
level of abundance conservation, with more than 3400 or-
thologous proteins observed in both, at an overall abundance
correlation of 0.7 (Fig. 3A). At the other end of the spec-
trum, distant comparisons across the root of the tree of life
(e.g. Bacteria versus Eukaryotes) reveal a universal core of
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Figure 3. Abundance conservation and stoichiometry (A) Abundance correlations among orthologous proteins, across different evolution-
ary distances. (B) Inferred stoichiometry ratios between functionally related cellular processes, across multiple datasets, and organisms.
In this plot, each data point denotes one organism; the abundance averages were taken from the integrated datasets (where available).
Boxplots denote themedians, as well as the 25 and 75% percentiles, respectively. Below each boxplot, themedian is also indicated textually.
With the exception of the two ribosomal subunits, all stoichiometries are significantly different from 1:1 (p-values are indicated). All data
in this figure are from version 3.0 of PaxDb.
the proteome—mostly involved in information process-
ing, but still with an abundance correlation approaching
0.5 overall.
When combined with information on protein complexes
or pathways, the view across multiple organisms might un-
ravel general pathway-stoichiometries and scaling laws in pro-
teome composition. With individual proteins and pathways,
the measurement noise is likely still too large to allow many
meaningful conclusions [30], but integration across datasets
and organisms may allow to constrain global stoichiometries
and min/max levels of regulation. This is explored in Fig. 3B:
it shows the relative abundance ratios between functionally
connected protein complexes (or processes), such as between
the two subunits of the ribosome, between the ribosome and
the proteasome, or between translation and transcription.
Since multiple organisms, datasets, and proteins contribute
data points to this plot, the ratios are statistically meaningful
and reveal the expected differences of scale. Strikingly, the
final abundance ratio of the two subunits of the ribosome
comes down to 1:1.03 (Fig. 3B), which is very close to the
theoretical expectation, and illustrates the quantitative power
of data aggregation. Another notable observation concerns
the stoichiometry between the core machineries of transla-
tion and transcription. Overall, this ratio is about 10:1, but
it is significantly higher in eukaryotes than in prokaryotes
(p < 2e-05; Fig. 3B), perhaps owing to larger cell-sizes and
slower growth.
These and similar studies represent some of the use cases
that PaxDb was designed for, but many other usage scenarios
will undoubtedly surface with each new data release.
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